Market Capitalization

Riding high on record 2025 results and a new FDA approval, LivaNova faces intense scrutiny ahead of its May 6 earnings call. Can it sustain the momentum?

The space company quadruples its manufacturing space to chase defense contracts, but faces a tough financial reality and a crowded market.

Following a 40-year career shaping biotech finance, Jessica Chutter's move to PTC's board signals major strategic ambitions for the rare disease firm.

With two renowned physician leaders, Pediatrix signals a major push into AI-driven innovation and health equity for maternal and child medicine.

Struggling in the furniture market, XMax Inc. is making a bold leap into AI. But can a small furniture firm compete with tech giants?

Rithm Capital declared its 52nd straight dividend. Is its high yield and analyst praise enough to overcome recent stock woes and market skepticism?

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

A new partnership between Hyperion DeFi and Silhouette gives all traders access to elite-level fees on the fast-growing Hyperliquid blockchain.

The non-prime lender struck a deal with lenders to ensure liquidity, but it comes at a high price amid massive loan losses and scrutiny of its LendCare unit.

With the appointment of Jack Azagury as CEO, Insight Enterprises signals an aggressive pivot to AI, banking on his transformation expertise to lead a new era.

Use your favorite Xbox or Switch Pro controller on the PS5 with no compromises. Brook's new adapter promises zero lag and full features. We dive in.

Land & Buildings urges shareholders to oust two directors at First Industrial Realty, alleging underperformance and an “insular” board culture.

Health-Ade's new campaign with Lindsay Lohan is more than celebrity sparkle; it's a calculated play for the booming wellness market. Here's the inside story.

Revenue intelligence leader 6sense appoints Kimberly Bloomston and Kelly Hopping to accelerate AI innovation and cement its dominance in the B2B tech market.

Biotech firm Humacyte raises $20M to accelerate sales of its FDA-approved Symvess® and fund crucial trials for new hemodialysis applications.

With the launch of Crimson Desert, MAINGEAR drops a hyper-exclusive PC. Only 30 exist, packing elite AMD hardware for a cool $4,499. Is it worth it?

For the 12th straight year, TE Connectivity is one of Ethisphere's Most Ethical Companies. What does this sustained commitment to integrity mean for the tech industry?

As AI valuations soar and IPOs loom, one veteran wealth manager warns of a familiar pattern. Are we witnessing innovation or another dot-com-style bubble?

The supply chain software firm nearly doubles its share repurchase plan, signaling deep confidence amid a strategic push for AI innovation and global growth.

Aerospace tech firm Merlin lands on NASDAQ, securing capital to scale its AI-powered autonomous flight system for military and future civilian aircraft.